Latest news with #PharmacyServices
The Sun
2 days ago
- Health
- The Sun
MOH bans two cosmetic products containing harmful poisons in Malaysia
KUALA LUMPUR: The Ministry of Health (MOH) has revoked the notification of two cosmetic products for containing scheduled poisons. The banned products are JC Beauty Culture Radiance Renewal Serum and The Perfect Derma Cream. MOH confirmed the serum contained hydroquinone and tretinoin, while the cream had miconazole. 'The notifications of the two cosmetic products have been revoked by the Director of Pharmacy Services, MOH,' the statement said. Hydroquinone, tretinoin, and miconazole are classified as medicines requiring professional supervision. Unsupervised use of hydroquinone can cause skin redness, discomfort, and discolouration. Tretinoin may lead to peeling, pain, and heightened sun sensitivity. Miconazole misuse increases resistance risks, reducing its effectiveness against infections. MOH also flagged Chang-Sze-Long Badu Gao, a traditional patch product, for excessive mercury levels. The product has been withdrawn, and its registration revoked by the Drug Control Authority. Mercury exposure can damage kidneys, the nervous system, and children's brain development. Skin issues like rashes and discolouration may also occur from mercury contamination. Consumers using these products are advised to stop immediately and seek medical help if needed. Sellers and distributors must halt sales to comply with the Control of Drugs and Cosmetics Regulations 1984. - Bernama
New Straits Times
2 days ago
- Health
- New Straits Times
Health Ministry bans sales of two cosmetics found with scheduled poisons
KUALA LUMPUR: The Health Ministry has revoked the notification of two cosmetic products because they are found to contain scheduled poisons and are no longer allowed to be sold in Malaysia. In a statement today, the ministry said that the products are JC Beauty Culture Radiance Renewal Serum, as it contained hydroquinone and tretinoin, and The Perfect Derma Cream because it contained miconazole. "As such, the notifications of the two cosmetic products have been revoked by the Director of Pharmacy Services," read the statement. It said cosmetics containing hydroquinone, tretinoin and miconazole are medicines that must be registered with the Drug Control Authority and can only be used with the advice of a health professional because their use without supervision can cause unwanted side effects. "Hydroquinone causes redness on the skin where it is applied, discomfort, unwanted skin discolouration and the skin becomes hypersensitive, while tretinoin causes the skin to become red, uncomfortable, painful, peeling and hypersensitive to sunlight. The ministry said that uncontrolled use of miconazole can increase the risk of resistance, thereby reducing its effectiveness in treating future infections. Meanwhile, the ministry also detected a registered traditional product, Chang-Sze-Long Badu Gao (patch type), that contained mercury levels exceeding the permitted limit. As such, the product has been withdrawn from the market, and its registration has been revoked by the Drug Control Authority. Excessive mercury exposure can cause kidney and nervous system damage, impair brain development in children, including unborn babies, and lead to skin problems such as rashes, irritation and discolouration," the statement said. Members of the public currently using the product are advised to stop immediately and seek medical advice if they experience any discomfort or adverse effects. Therefore, it urged sellers and distributors to stop selling and distributing the products concerned immediately, as it violates the Control of Drugs and Cosmetics Regulations 1984.
Yahoo
07-06-2025
- Health
- Yahoo
Cancer patients facing digestion drug shortage
Pharmacists in the Channel Islands have confirmed they are dealing with an ongoing shortage of a drug used by cancer patients. It follows a shortage of Creon, a pancreatic enzyme replacement therapy (Pert), being described by pharmacists in the UK as "one of the worst" examples of a medicine shortage. The drug does not treat cancer but is used by patients with pancreatic cancer, cystic fibrosis and chronic pancreatitis to help with digestion. A spokesperson from the Guernsey Prescribing Support Unit said there have been ongoing supply issues with Pert since summer 2024, with the department of health in England issuing a national patient safety alert in December 2024. The spokesperson said: "Local pharmacies have been working hard to help maintain supplies of medication for patients and at times this has proved difficult." They said there were an average of 70 Pert prescriptions dispensed each month in Guernsey, but they haven't received any reports of patients going without the drug. This was testament to the efforts of community pharmacy teams, the spokesperson added. The acting director of Pharmacy Services in Jersey, Kevin Smith, said the shortage of these medicines was expected to continue for many months. He said Jersey has introduced measures to help manage local supplies, such as issuing shorter prescription durations. Clinical and pharmacy teams were working with the hospital to find suitable alternative treatments where needed, he added. Jersey oncology consultant, Elizabet Gomes Dos Santos, said: "Patient safety remains our highest priority. "We are committed to maintaining the highest standards of care and ensuring that all patients continue to receive the support they need during this period of constrained supply." Follow BBC Guernsey on X and Facebook. Follow BBC Jersey on X and Facebook. Send your story ideas to Islanders reminded to pay prescription charges Cancer charity fears lack of drug could cost lives Cancer patients get quicker access to medication
BBC News
07-06-2025
- Health
- BBC News
Channel Island pharmacists confirm digestion drug shortage
Pharmacists in the Channel Islands have confirmed they are dealing with an ongoing shortage of a drug used by cancer follows a shortage of Creon, a pancreatic enzyme replacement therapy (Pert), being described by pharmacists in the UK as "one of the worst" examples of a medicine drug does not treat cancer but is used by patients with pancreatic cancer, cystic fibrosis and chronic pancreatitis to help with digestion.A spokesperson from the Guernsey Prescribing Support Unit said there have been ongoing supply issues with Pert since summer 2024, with the department of health in England issuing a national patient safety alert in December 2024. The spokesperson said: "Local pharmacies have been working hard to help maintain supplies of medication for patients and at times this has proved difficult."They said there were an average of 70 Pert prescriptions dispensed each month in Guernsey, but they haven't received any reports of patients going without the was testament to the efforts of community pharmacy teams, the spokesperson added. The acting director of Pharmacy Services in Jersey, Kevin Smith, said the shortage of these medicines was expected to continue for many said Jersey has introduced measures to help manage local supplies, such as issuing shorter prescription and pharmacy teams were working with the hospital to find suitable alternative treatments where needed, he added. Jersey oncology consultant, Elizabet Gomes Dos Santos, said: "Patient safety remains our highest priority. "We are committed to maintaining the highest standards of care and ensuring that all patients continue to receive the support they need during this period of constrained supply."
